Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Roshal, Mikhail  [Clear All Filters]
2024
Krystel-Whittemore M, Petrova-Drus K, Ptashkin RN, Ewalt MD, Yao JJ, Liu Y, Zhu M, Benhamida J, Durham B, Kumar J, et al. Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies. Haematologica. 2024.
2023
Ptashkin RN, Ewalt MD, Jayakumaran G, Kiecka I, Bowman AS, Yao JJ, Casanova J, Lin Y-TDavid, Petrova-Drus K, Mohanty AS, et al. Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing. Nat Commun. 2023;14(1):6895.
Diamond BT, Ziccheddu B, Maclachlan KH, Taylor J, Boyle EMary, Ossa JEsteban Ar, Jahn TJacob, Affer M, Totiger TM, Coffey DG, et al. Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures. Blood. 2023.
2022
Ramaswamy K, Steinherz P, Agrawal AK, Forlenza CJon, Mauguen A, Roshal M, Trippett T, Kernan NA, Sulis MLuisa, Shukla NNarendra. Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML. Blood Adv. 2022.
Wudhikarn K, King AC, Geyer MBlaine, Roshal M, Bernal Y, Gyurkocza B, Perales M-A, Park JH. Outcomes of Relapsed B-Cell Acute Lymphoblastic Leukemia After Sequential Treatment with Blinatumomab and Inotuzumab. Blood Adv. 2022.
2021
Miltiadous O, Petrova-Drus K, Kaicker S, Mathew S, Kluk M, Geyer JTurbiner, M Rodriguez-Sanchez I, Bouvier N, Inghirami GGa, Stieglitz E, et al. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm. Blood Adv. 2021.
2020
Bal S, Landau HJ, Shah GL, Scordo M, Dahi P, Lahoud OB, Hassoun H, Hultcrantz M, Korde N, Lendvai N, et al. Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity 1 with Novel Induction Regimens in Multiple Myeloma. Biol Blood Marrow Transplant. 2020.